
Oncologist

No OPD information available
Melanoma
Anal Cancer
Brain Tumor
Chronic B-Cell Leukemia (CBCL)
Chronic Lymphocytic Leukemia (CLL)
Goodpasture Syndrome
Hepatitis
Hepatitis B
Interstitial Nephritis
Lung Metastases
Melasma
Metastatic Brain Tumor
Neuroendocrine Tumor
Small Lymphocytic Lymphoma (SLL)
Victoria G. Atkinson is a female healthcare provider who helps patients with various medical conditions like melanoma, anal cancer, brain tumor, chronic B-cell leukemia, chronic lymphocytic leukemia, Goodpasture syndrome, hepatitis, hepatitis B, interstitial nephritis, lung metastases, melasma, metastatic brain tumor, neuroendocrine tumor, and small lymphocytic lymphoma.
Victoria G. Atkinson uses special skills and treatments to care for patients with these conditions. She communicates with patients in a way that makes them feel comfortable and understood, which is why patients trust her. She stays updated with the latest medical knowledge and research to provide the best care possible.
Victoria G. Atkinson works well with her colleagues and other medical professionals, collaborating effectively to ensure patients receive comprehensive care. Her approach to teamwork benefits patients by providing them with a holistic and coordinated treatment plan.
Through her work, Victoria G. Atkinson has positively impacted many patients' lives and health. She has conducted notable research, such as the study on Tilsotolimod in combination with Ipilimumab for advanced refractory melanoma, which was published in a prestigious medical journal. She is also involved in clinical trials, like the one studying LY3200882 in patients with solid tumors.
Overall, Victoria G. Atkinson is a dedicated healthcare provider who uses her expertise and compassion to improve the lives of her patients. Her commitment to staying informed, collaborating with colleagues, and conducting research demonstrates her passion for delivering high-quality care to those in need.
Enrollment Status: Active not recruiting
Published: February 28, 2025
Intervention Type: Drug, Radiation
Study Drug:
Study Phase: Phase 1
